Why This Top-Notch Biotech Stock Just Plunged By Double Digits

Why This Top-Notch Biotech Stock Just Plunged By Double Digits

Shares of highly rated biotech company Arrowhead Pharmaceuticals crashed to a two-month low Tuesday after an analyst initiated coverage of ARWR stock with an underperform rating.